2010 annual financial data

Corcept Therapeutics 2010 Operating margin

Corcept Therapeutics 2010 operating margin with verified reported values.

Direct answer

Operating margin was Not calculable.

Operating income was -27,437,000 USD and net income was -25,966,000 USD.
Operating cash flow was -22,285,000 USD.

Get free Corcept Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
Not available
Operating income
-27,437,000 USD
Net income
-25,966,000 USD
Operating cash flow
-22,285,000 USD